Introducing OneBioSM Suite Accelerating timelines through integrated biologics development, manufacturing & supply Learn More Your one comprehensive BIOLOGICS partner Helping simplify your process and deliver better therapies to your patients faster Play Video Catalent Has Acquired Paragon Bioservices Combining Leaders in Gene Therapy & Complex Biologics Learn More Introducing OneBioSM Suite Reducing timelines, risk & complexity through integrated biologics development, manufacturing & supply Learn More Your one comprehensive BIOLOGICS partner Helping simplify your process and deliver better therapies to your patients faster Play Video Catalent Has Acquired Paragon Bioservices Combining Leaders in Gene Therapy & Complex Biologics Learn More How can we work together BiologicsDevelopment Drug SubstanceBiomanufacturing Drug ProductFill / Finish Clinical SupplyServices Latest News Catalent Biologics Announces Agreement to Provide Additional Production of Approved Gene Therapy Treatment for Spinal Muscular Atrophy WEBINAR: CASE STUDIES IN EXPEDITING BIOLOGIC DEVELOPMENT Biologic drug development is complex, which can add costs and delays. This webinar covers challenges and tools for risk mitigation during biologic development and manufacturing. Analytical Comprehensive integrated and standalone bioanalytical services for drug substance, drug product and intermediates, both new biologic entities and biosimilars/biobetters. Join Our Team Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. Biologics Network Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. See all of our locations NEWS Catalent Announces the Appointment of David Schaffer to Biologics Advisory Board Flexible Filling And Adoption Of ‘Ready-to-Use’ Technologies To Be Discussed By Catalent Biologics At The Pharma Forum Novavax and Catalent Announce Closing of Strategic Partnership Catalent Biologics Announces Agreement to Provide Additional Production of Approved Gene Therapy Treatment for Spinal Muscular Atrophy EVENTS Pharma Forum Webinar | From Basics To Best Practices: Exploring Bioassays And Binding Assays Contract Pharma Cell and Gene Meeting On The Mesa EXPERT CONTENT Advances in Analytical Technology for Biopharmaceuticals Prefilled Syringes & Parental Manufacturing Accelerating Method Transfer: Effective Automation Of Biological Assays
